SARS-CoV-2 utilizes ACE2 as a receptor to infiltrate cells, with higher levels of this enzyme found in the respiratory tract epithelial cells, particularly in individuals with COPD [24]. This evidence concerns the gene ACE2 and chronic obstructive pulmonary disease.